Publication Archive
Publication search

We found 245 results:
  • Bain SC, Skrivanek Z, Tahbaz A, Pechtner V, Adetunji O. Efficacy of long-acting once weekly dulaglutide compared with short-acting twice daily (bid) exenatide in patients with Type 2 diabetes: a posthoc analysis to determine the influence of baseline HbA1c in the Assessment of Weekly Administration of LY2189265 in Diabetes-1 (AWARD-1) trial.  Diabetic Medicine, 2014

  • Adetunji O, Skrivanek Z, Tahbaz A, Bain SC, Pechtner V. A posthoc pooled analysis of two placebo-controlled phase 3 trials, Assessment of Weekly Administration of LY2189265 in Diabetes 1 and 5 (AWARD-1 and AWARD-5): dulaglutide compared with exenatide, sitagliptin and placebo. Diabetic Medicine, 2014  

  • Campbell MD, West DJ, Bain SC, Kingsley MIC, Foley P, Turner D, Gray BJ, Stephens JW, Bracken RM. Reduced risk of early-onset but not late-onset post-exercise hypoglycaemia following intermittent games-type activity in Type 1 diabetes patients. Diabetic Medicine 2014

  • Campbell MD, Walker M, Trenell MI, Stevenson EJ, Luzio S, Dunseath G, Bain SC, Bracken RM, Turner D, West DJ. Heavily reducing pre- and post-exercise rapid-acting insulin dose may cause hyperglycaemia, but does not augment ketonaemia or increase inflammatory cytokines in patients with Type 1 diabetes. Diabetic Medicine, 2014

  • Turner D,  Gray BJ, West DJ, Campbell MD, Hanley S, Luzio S, Dunseath G, Bain SC, Bracken RM. Similar magnitude of post-exercisehyperglycaemia following moderate and low intensity resistance exercise in individuals with Type 1 diabetes. Diabetic Medicine 2014

  • Thayer D, Sayers A, Harvey J, Atkinson M, Warner J, Wong S, Dayan CM, Luzio S, Gregory J. Hospital admissions in young people with Type 1 diabetes: results from a large national matched cohort study. Diabetic Medicine 2014

  • Harvey JN, Hibbs R, O’Connell H, Gregory JW. A stable incidence rate of childhood onset Type 1 diabetes in Wales: the influence of birth cohort. Diabetic Medicine, 2014

  • Gray BJ, Bracken RM, Turner D, Morgan K, Mellalieu SD, Thomas M, Williams SP, Williams M, Rice S, Stephens JW. Categorising individuals at high risk of Type 2 diabetes is dependent on which validated risk assessment is used. Diabetic Medicine, 2014

  • Gray BJ, Bracken RM, Turner D, Morgan K, Mellalieu SD, Thomas M, Williams SP, Williams M, Rice S, Stephens JW.  HbA1c values are associated with changes in risk scores in four commonly used validated diabetes risk assessment tools. Diabetic Medicine, 2014 

  • Bain SC, Shomali M, Blonde L, Svendsen CB, Thomsen H, Zinman B. Greater postprandial glucose control across all three daily meals with liraglutide compared with placebo when added to metformin and rosiglitazone in patients with Type 2 diabetes: posthoc analysis of Liraglutide Effect and Action on Diabetes (LEAD)4. Diabetic Medicine, 2014